TR199902546T2 - Serotoninerjik maddeler olarak indazol amit bile�ikleri. - Google Patents

Serotoninerjik maddeler olarak indazol amit bile�ikleri.

Info

Publication number
TR199902546T2
TR199902546T2 TR1999/02546T TR9902546T TR199902546T2 TR 199902546 T2 TR199902546 T2 TR 199902546T2 TR 1999/02546 T TR1999/02546 T TR 1999/02546T TR 9902546 T TR9902546 T TR 9902546T TR 199902546 T2 TR199902546 T2 TR 199902546T2
Authority
TR
Turkey
Prior art keywords
amide compounds
serotoninergic agents
indazole amide
indazole
serotoninergic
Prior art date
Application number
TR1999/02546T
Other languages
English (en)
Turkish (tr)
Inventor
Alisi Alessandra
Brufani Mario
Cazzolla Nicola
Giannangeli Marilena
Pinza Mario
Original Assignee
Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F.
S.P.A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F., S.P.A filed Critical Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F.
Publication of TR199902546T2 publication Critical patent/TR199902546T2/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Urology & Nephrology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Paints Or Removers (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
TR1999/02546T 1997-04-15 1998-04-02 Serotoninerjik maddeler olarak indazol amit bile�ikleri. TR199902546T2 (xx)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT97MI000867A IT1291569B1 (it) 1997-04-15 1997-04-15 Indazolammidi come agenti serotoninergici

Publications (1)

Publication Number Publication Date
TR199902546T2 true TR199902546T2 (xx) 2000-05-22

Family

ID=11376888

Family Applications (1)

Application Number Title Priority Date Filing Date
TR1999/02546T TR199902546T2 (xx) 1997-04-15 1998-04-02 Serotoninerjik maddeler olarak indazol amit bile�ikleri.

Country Status (26)

Country Link
US (1) US6197769B1 (enExample)
EP (1) EP0975623B1 (enExample)
JP (2) JP4578581B2 (enExample)
KR (1) KR100563867B1 (enExample)
CN (1) CN1318416C (enExample)
AR (1) AR012426A1 (enExample)
AT (1) ATE219490T1 (enExample)
AU (1) AU740360B2 (enExample)
BG (1) BG64006B1 (enExample)
CA (1) CA2286870C (enExample)
CZ (1) CZ295190B6 (enExample)
DE (1) DE69806141T2 (enExample)
DK (1) DK0975623T3 (enExample)
EA (1) EA002352B1 (enExample)
ES (1) ES2178205T3 (enExample)
GE (1) GEP20022654B (enExample)
HU (1) HU227973B1 (enExample)
IL (1) IL132127A (enExample)
IT (1) IT1291569B1 (enExample)
PL (1) PL193308B1 (enExample)
PT (1) PT975623E (enExample)
SK (1) SK284731B6 (enExample)
TR (1) TR199902546T2 (enExample)
UA (1) UA58550C2 (enExample)
WO (1) WO1998046589A2 (enExample)
ZA (1) ZA982926B (enExample)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1291569B1 (it) * 1997-04-15 1999-01-11 Angelini Ricerche Spa Indazolammidi come agenti serotoninergici
BR0207526A (pt) 2001-02-23 2004-03-09 Merck & Co Inc Composto, composição farmacêutica, e, métodos para o tratamento da dor, da enxaqueca, depressão, ansiedade, esquizofrenia, doença de parkinson ou derrame cerebral
US7259157B2 (en) 2001-04-03 2007-08-21 Merck & Co., Inc. N-substituted nonaryl-heterocyclo amidyl NMDA/NR2B Antagonists
ITMI20030287A1 (it) 2003-02-18 2004-08-19 Acraf Indazolammidi dotate di attivita' analgesica metodo, per
ITMI20030972A1 (it) * 2003-05-15 2004-11-16 Acraf Indazolo dotato di attivita' analgesica, metodo per prepararlo e composizione farmaceutica che lo comprende.
ITMI20031468A1 (it) * 2003-07-18 2005-01-19 Acraf Farmaco ativo nel dolore neuropatico
TW200533348A (en) * 2004-02-18 2005-10-16 Theravance Inc Indazole-carboxamide compounds as 5-ht4 receptor agonists
US8309575B2 (en) 2004-04-07 2012-11-13 Theravance, Inc. Quinolinone-carboxamide compounds as 5-HT4 receptor agonists
US7728006B2 (en) * 2004-04-07 2010-06-01 Theravance, Inc. Quinolinone-carboxamide compounds as 5-HT4 receptor agonists
TWI351282B (en) 2004-04-07 2011-11-01 Theravance Inc Quinolinone-carboxamide compounds as 5-ht4 recepto
ATE431824T1 (de) * 2004-11-05 2009-06-15 Theravance Inc Chinolinon-carboxamid-verbindungen
ATE441646T1 (de) * 2004-11-05 2009-09-15 Theravance Inc 5-ht4-rezeptoragonistenverbindungen
WO2006069125A1 (en) * 2004-12-22 2006-06-29 Theravance, Inc. Indazole-carboxamide compounds
JP2008530225A (ja) * 2005-02-17 2008-08-07 セラヴァンス， インコーポレーテッド インダゾール−カルボキサミド化合物の結晶型
WO2006094063A1 (en) * 2005-03-02 2006-09-08 Theravance, Inc. Quinolinone compounds as 5-ht4 receptor agonists
ITMI20062230A1 (it) * 2006-11-22 2008-05-23 Acraf Composto 2-alchil-indazolico procedimento per preparalo e composizione farmaceutica che lo comprende
UA99927C2 (uk) * 2007-11-12 2012-10-25 Ацьенде Кимике Риуните Анджелини Франческо А.Чи.Р.А.Ф. С.П.А. Медикамент, який є активним при невропатичному болі
US8377968B2 (en) 2008-06-02 2013-02-19 Zalicus Pharmaceuticals, Ltd. N-piperidinyl acetamide derivatives as calcium channel blockers
WO2012169649A1 (en) * 2011-06-07 2012-12-13 Dainippon Sumitomo Pharma Co., Ltd. Indazole- and pyrrolopyridine-derivative and pharmaceutical use thereof
AU2013224313B2 (en) * 2012-02-21 2017-03-30 Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F. S.P.A. Use of 1H-indazole-3-carboxamide compounds as glycogen synthase kinase 3 beta inhibitors
SG10201701649YA (en) * 2012-02-21 2017-04-27 Acraf 1h-indazole-3-carboxamide compounds as glycogen synthase kinase 3 beta inhibitors
WO2014134306A1 (en) 2013-03-01 2014-09-04 Zalicus Pharmaceuticals, Ltd. Heterocyclic inhibitors of the sodium channel
JP2022540253A (ja) 2019-07-11 2022-09-14 プラクシス プレシジョン メディシンズ， インコーポレイテッド Ｔ型カルシウムチャネル調節因子の製剤およびその使用方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9103862D0 (en) * 1991-02-25 1991-04-10 Glaxo Group Ltd Chemical compounds
PT100785A (pt) * 1991-08-20 1994-04-29 Smithkline Beecham Plc Utilizacao de compostos, por exemplo indole-3-carboxilatos, para a producao de medicamentos, compostos ai utilizados e composicoes farmaceuticas que os contem.
IL117438A (en) * 1995-03-16 2001-12-23 Lilly Co Eli Indazolecarboxamides, their preparation and pharmaceutical compositions containing them
WO1996038420A1 (en) * 1995-05-31 1996-12-05 Nisshin Flour Milling Co., Ltd. Indazole derivatives having monocyclic amino group
IT1291569B1 (it) * 1997-04-15 1999-01-11 Angelini Ricerche Spa Indazolammidi come agenti serotoninergici

Also Published As

Publication number Publication date
KR20010006120A (ko) 2001-01-26
DE69806141T2 (de) 2003-01-30
SK142399A3 (en) 2000-08-14
EP0975623A2 (en) 2000-02-02
IL132127A (en) 2005-06-19
PT975623E (pt) 2002-10-31
CA2286870A1 (en) 1998-10-22
PL336348A1 (en) 2000-06-19
DK0975623T3 (da) 2002-10-14
AR012426A1 (es) 2000-10-18
KR100563867B1 (ko) 2006-03-24
BG64006B1 (bg) 2003-09-30
EP0975623B1 (en) 2002-06-19
US6197769B1 (en) 2001-03-06
HUP0002057A3 (en) 2002-01-28
ES2178205T3 (es) 2002-12-16
CN1252798A (zh) 2000-05-10
JP2001518906A (ja) 2001-10-16
JP2010195813A (ja) 2010-09-09
UA58550C2 (uk) 2003-08-15
ATE219490T1 (de) 2002-07-15
CZ295190B6 (cs) 2005-06-15
WO1998046589A3 (en) 1999-01-28
DE69806141D1 (de) 2002-07-25
EA002352B1 (ru) 2002-04-25
HU227973B1 (hu) 2012-07-30
BG103863A (en) 2000-07-31
AU740360B2 (en) 2001-11-01
IL132127A0 (en) 2001-03-19
WO1998046589A2 (en) 1998-10-22
CN1318416C (zh) 2007-05-30
ZA982926B (en) 1998-10-09
CZ362599A3 (cs) 2000-04-12
PL193308B1 (pl) 2007-01-31
JP5237324B2 (ja) 2013-07-17
EA199900935A1 (ru) 2000-04-24
HK1027811A1 (en) 2001-01-23
ITMI970867A1 (it) 1998-10-15
IT1291569B1 (it) 1999-01-11
AU7215998A (en) 1998-11-11
CA2286870C (en) 2007-05-22
SK284731B6 (sk) 2005-10-06
HUP0002057A2 (hu) 2001-04-28
GEP20022654B (en) 2002-03-25
JP4578581B2 (ja) 2010-11-10

Similar Documents

Publication Publication Date Title
TR199902546T2 (xx) Serotoninerjik maddeler olarak indazol amit bile�ikleri.
CA2260337A1 (en) Therapeutic agents
NO2001003I1 (no) Gadovist
BG104670A (en) 4-(2-keto-1-benzimidazolinyl)piperidinne compounds as orl1-receptor agonists
CA2160447A1 (en) Amino(thio)ether derivatives
CA2311742A1 (en) 6-amino-9-benzyl-8-hydroxypurine derivatives
TR200100075T2 (tr) 2-Kuinolon ihtiva eden farmasötik bileşimler
GB9929552D0 (en) Compounds
ATE155465T1 (de) Phenoxy- oder phenoxyalkyl-piperidine als antivirale mittel
ES2181853T3 (es) Tratamiento del tinnitus empleando agentes neuroprotectores.
AP9801321A0 (en) 2-(4-aryl or heteroaryl-piperazin-1-ylmethyl)-h-indole derivatives.
MY117092A (en) Chemotherapeutic pyrrolocarbazole derivatives
DK0916651T3 (da) Phenylalkylcarboxylsyrederivater
TR200002580T2 (tr) Hücre çoğalmasının engellenmesinde kullanılan ikameli bisindolimaleimitler
TR200201128T2 (tr) PDE4 inhibitörleri olarak tetrahidrotiyopiranfitalazinon türevleri.
TR200001909T2 (tr) Matris metaloprotez inhibitörleri.
CA2356985A1 (en) 5ht1 antagonists for antidepressant therapy
HRP20010885B1 (en) Ethanesulfonyl-piperidine derivatives
ATE374189T1 (de) Phthalazinon-derivate als pde 4 hemmer
DK0777653T3 (da) Dihydropyridinderivater som bradykininantagonister
TW350840B (en) N-acylpiperazine derivative, antibacterial drug and anti-ulcer drug
NO994104L (no) 5-hydroksymetyl-2-aminotetraliner i form av kardiovaskulaere midler
DE69423055D1 (de) Indol Derivate als Glutamat Antagonisten
CA2211681A1 (en) Novel pyridonecarboxylic acid derivatives or salts thereof and antibacterial agents comprising the same as active ingredient
KR970706280A (ko) 5-HT1A 길항제로서의 비사이클릭 카복스아미드(Bicyclic carboxamides as 5-HT1 antagonists)